DK1715859T3 - Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden - Google Patents

Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden

Info

Publication number
DK1715859T3
DK1715859T3 DK05711057T DK05711057T DK1715859T3 DK 1715859 T3 DK1715859 T3 DK 1715859T3 DK 05711057 T DK05711057 T DK 05711057T DK 05711057 T DK05711057 T DK 05711057T DK 1715859 T3 DK1715859 T3 DK 1715859T3
Authority
DK
Denmark
Prior art keywords
zonisamide
treating
osa
sleep
carrying
Prior art date
Application number
DK05711057T
Other languages
Danish (da)
English (en)
Inventor
Jan Hedner
Ludger Grote
Kaj Stenloef
Original Assignee
Cereuscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cereuscience Ab filed Critical Cereuscience Ab
Application granted granted Critical
Publication of DK1715859T3 publication Critical patent/DK1715859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Test And Diagnosis Of Digital Computers (AREA)
DK05711057T 2004-02-17 2005-02-15 Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden DK1715859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
PCT/SE2005/000196 WO2005077362A1 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method

Publications (1)

Publication Number Publication Date
DK1715859T3 true DK1715859T3 (da) 2009-02-16

Family

ID=31974257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05711057T DK1715859T3 (da) 2004-02-17 2005-02-15 Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden

Country Status (14)

Country Link
US (1) US7655681B2 (de)
EP (1) EP1715859B1 (de)
JP (1) JP2007523079A (de)
CN (1) CN100558358C (de)
AT (1) ATE410163T1 (de)
AU (1) AU2005212149B2 (de)
CA (1) CA2555149C (de)
DE (1) DE602005010213D1 (de)
DK (1) DK1715859T3 (de)
ES (1) ES2317196T3 (de)
NZ (1) NZ548943A (de)
SE (1) SE0400378D0 (de)
SI (1) SI1715859T1 (de)
WO (1) WO2005077362A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
EP1928445A1 (de) * 2005-09-16 2008-06-11 Cereuscience AB Verfahren und mittel zur prävention und behandlung von atemstörungen im schlaf
CA2630624C (en) 2005-11-22 2013-08-06 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
WO2007062228A1 (en) * 2005-11-28 2007-05-31 Orexigen Therapeutics, Inc. Sustained-release formulation of zonisamide
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20180066272A (ko) 2006-11-09 2018-06-18 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
BR112012016799A2 (pt) * 2010-01-07 2019-10-08 Vivus Inc tratamento da síndrome de apneia obstrutiva do sono com uma combinação de um inibidor da anidrase carbônica e um agente ativo adicional
MX344303B (es) 2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
EP2854636B1 (de) * 2012-05-30 2019-08-21 ResMed Sensor Technologies Limited Verfahren und vorrichtung zur überwachung der kardiopulmonaren gesundheit
IL300868A (en) 2012-06-06 2023-04-01 Orexigen Therapeutics Inc Methods for treating overweight and obesity
US10525219B2 (en) 2012-06-26 2020-01-07 Resmed Sensor Technologies Limited Methods and apparatus for monitoring and treating respiratory insufficiency
WO2017194551A1 (en) 2016-05-11 2017-11-16 Jan Hedner Sultiame for the treatment of sleep apnea
CN112259179A (zh) * 2020-10-09 2021-01-22 首都医科大学宣武医院 一种患者日志生成方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509349A (ja) * 1999-09-15 2003-03-11 エラン ファーマシューティカルズ，インコーポレイテッド ヘテロアリールメタンスルホンアミドを使用するニューロパシー性疼痛を処置するための方法。
SE0000601D0 (sv) * 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
CA2483464C (en) * 2002-05-17 2011-12-20 Duke University Method for treating obesity

Also Published As

Publication number Publication date
SE0400378D0 (sv) 2004-02-17
CN1917874A (zh) 2007-02-21
NZ548943A (en) 2010-06-25
EP1715859A1 (de) 2006-11-02
EP1715859B1 (de) 2008-10-08
US7655681B2 (en) 2010-02-02
CA2555149A1 (en) 2005-08-25
ES2317196T3 (es) 2009-04-16
DE602005010213D1 (de) 2008-11-20
CN100558358C (zh) 2009-11-11
US20070281005A1 (en) 2007-12-06
ATE410163T1 (de) 2008-10-15
JP2007523079A (ja) 2007-08-16
SI1715859T1 (sl) 2009-06-30
AU2005212149A1 (en) 2005-08-25
WO2005077362A1 (en) 2005-08-25
AU2005212149B2 (en) 2010-02-11
CA2555149C (en) 2014-01-21

Similar Documents

Publication Publication Date Title
DK1715859T3 (da) Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden
Tingting et al. Non-surgical treatment of obstructive sleep apnea syndrome
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
DK1742624T3 (da) Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
JP2009539961A5 (de)
NO20064964L (no) Behandling av svekket respiratorisk funksjon
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
DE502005010170D1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
JP2009537553A5 (de)
MX2009011900A (es) Curacion de herida diabetica.
PT2111868E (pt) Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos
Giannasi et al. Efficacy of an oral appliance for the treatment of obstructive sleep apnea.
SE0000601D0 (sv) Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
EA200701077A1 (ru) Применение конъюгатов липидов при лечении заболеваний
WO2006063038A3 (en) Treating sleep deprivation using anesthetic agent
WO2005110052A3 (en) The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
ATE375146T1 (de) Schleimdrogenbasierte lutschtablette gegen entzündliche erkrankungen des mund- und rachenraums
JP2010523662A5 (de)
RU2009141168A (ru) Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна
NO20091659L (no) Fremgangsmater for behandling av disruptive oppforselsforstyrrelser
MXPA04002401A (es) Nuevos medicamentos para inhalacion.